27794381|t|Effect of emodin on mobility signal transduction system of gallbladder smooth muscle in Guinea pig with cholelithiasis
27794381|a|To study the effect of emodin on protein and gene expressions of the massagers in mobility signal transduction system of cholecyst smooth muscle cells in guinea pig with cholesterol calculus. The guinea pigs were randomly divided into 4 groups, such as control group, gall-stone (GS) group, emodin group and ursodeoxycholic acid (UA) group. Cholesterol calculus models were induced in guinea pigs of GS, emodin and UA groups by lithogenic diet, while emodin or UA were given to the corresponding group for 7 weeks. The histomorphological and ultrastructure change of gallbladder were detected by microscope and electron microscope, the content of plasma cholecystokinin (CCK) and [Ca(2+)]i were analyzed successively by radioimmunoassay and flow cytometry. The protein and mRNA of Gsα, Giα and Cap in cholecyst cells were determined by western blotting and real time polymerase chain reaction (RT-PCR). Emodin or UA can relieve pathogenic changes in epithelial cells and muscle cells in gallbladder of guinea pig with cholesterol calculus by microscope and transmission electron microscope. In the cholecyst cells of GS group, CCK levels in plasma and [Ca(2+)]i decreased, the protein and mRNA of GS were down-regulated, the protein and mRNA of Gi and Cap were up-regulated. Emodin significantly decreased the formative rate of gallstone, improved the pathogenic change in epithelial cells and muscle cells, increased CCK levels in plasma and [Ca(2+)]i in cholecyst cells, enhanced the protein and mRNA of Gs in cholecyst cells, reduced the protein and mRNA of Gi and Cap in cholecyst cells in guinea pig with cholesterol calculus. The dysfunction of gallbladder contraction gives rise to the disorders of mobility signal transduction system in cholecyst smooth muscle cells, including low content of plasma CCK and [Ca(2+)]i in cholecyst cells, abnormal protein and mRNA of Gs, Gi and Cap. Emodin can enhance the contractibility of gallbladder and alleviate cholestasis by regulating plasma CCK levels, [Ca(2+)]i in cholecyst cells and the protein and mRNA of Gs, Gi and Cap.
27794381	0	6	Effect	T080	C1280500
27794381	10	16	emodin	T109,T121,T123	C0013982
27794381	20	55	mobility signal transduction system	T043	C0037083
27794381	59	70	gallbladder	T023	C0016976
27794381	71	84	smooth muscle	T024	C1267092
27794381	88	98	Guinea pig	T015	C0085979
27794381	104	118	cholelithiasis	T047	C0008350
27794381	122	127	study	T062	C2603343
27794381	132	138	effect	T080	C1280500
27794381	142	148	emodin	T109,T121,T123	C0013982
27794381	152	159	protein	T045	C1171362
27794381	164	180	gene expressions	T045	C0017262
27794381	188	197	massagers	UnknownType	C0815029
27794381	201	236	mobility signal transduction system	T043	C0037083
27794381	240	249	cholecyst	T023	C0016976
27794381	250	269	smooth muscle cells	T025	C0596981
27794381	273	283	guinea pig	T015	C0085979
27794381	289	309	cholesterol calculus	T031	C0333018
27794381	315	326	guinea pigs	T015	C0085979
27794381	356	362	groups	T078	C0441833
27794381	372	385	control group	T096	C0009932
27794381	387	397	gall-stone	T047	C1392480
27794381	399	401	GS	T047	C1392480
27794381	403	408	group	T078	C0441833
27794381	410	416	emodin	T109,T121,T123	C0013982
27794381	417	422	group	T078	C0441833
27794381	427	447	ursodeoxycholic acid	T109,T121,T123	C0042105
27794381	449	451	UA	T109,T121,T123	C0042105
27794381	453	458	group	T078	C0441833
27794381	460	480	Cholesterol calculus	T031	C0333018
27794381	481	487	models	T075	C0026336
27794381	504	515	guinea pigs	T015	C0085979
27794381	519	521	GS	T047	C1392480
27794381	523	529	emodin	T109,T121,T123	C0013982
27794381	534	536	UA	T109,T121,T123	C0042105
27794381	537	543	groups	T078	C0441833
27794381	547	562	lithogenic diet	T168	C0012155
27794381	570	576	emodin	T109,T121,T123	C0013982
27794381	580	582	UA	T109,T121,T123	C0042105
27794381	615	620	group	T078	C0441833
27794381	627	632	weeks	T079	C0439230
27794381	638	656	histomorphological	T080	C0332437
27794381	661	675	ultrastructure	T078	C0041623
27794381	676	682	change	T169	C0392747
27794381	686	697	gallbladder	T023	C0016976
27794381	703	711	detected	T033	C0442726
27794381	715	725	microscope	T074	C0181839
27794381	730	749	electron microscope	T074	C0181845
27794381	766	772	plasma	T031	C0032105
27794381	773	788	cholecystokinin	T116,T121,T125	C0008328
27794381	790	793	CCK	T116,T121,T125	C0008328
27794381	799	808	[Ca(2+)]i	T121,T196	C0596235
27794381	814	822	analyzed	T062	C0936012
27794381	839	855	radioimmunoassay	T059	C0034580
27794381	860	874	flow cytometry	T059	C0016263
27794381	880	887	protein	T116,T123	C0033684
27794381	892	896	mRNA	T114,T123	C0035696
27794381	900	903	Gsα	T116,T126	C0086903
27794381	905	908	Giα	T116,T126	C0086706
27794381	913	916	Cap	T116,T123	C0073423
27794381	920	929	cholecyst	T023	C0016976
27794381	930	935	cells	T025	C0596981
27794381	941	954	determined by	T080	C0521095
27794381	955	971	western blotting	T059,T063	C0005863
27794381	976	1011	real time polymerase chain reaction	T063	C1709846
27794381	1013	1019	RT-PCR	T063	C1709846
27794381	1022	1028	Emodin	T109,T121,T123	C0013982
27794381	1032	1034	UA	T109,T121,T123	C0042105
27794381	1047	1057	pathogenic	T033	C3816499
27794381	1058	1065	changes	T169	C0392747
27794381	1069	1085	epithelial cells	T025	C0014597
27794381	1090	1102	muscle cells	T025	C0596981
27794381	1106	1117	gallbladder	T023	C0016976
27794381	1121	1131	guinea pig	T015	C0085979
27794381	1137	1157	cholesterol calculus	T031	C0333018
27794381	1161	1171	microscope	T074	C0181839
27794381	1176	1208	transmission electron microscope	T074	C0262880
27794381	1217	1226	cholecyst	T023	C0016976
27794381	1227	1232	cells	T025	C0596981
27794381	1236	1238	GS	T047	C1392480
27794381	1239	1244	group	T078	C0441833
27794381	1246	1249	CCK	T116,T121,T125	C0008328
27794381	1250	1256	levels	T080	C0441889
27794381	1260	1266	plasma	T031	C0032105
27794381	1271	1280	[Ca(2+)]i	T121,T196	C0596235
27794381	1281	1290	decreased	T081	C0205216
27794381	1296	1303	protein	T116,T123	C0033684
27794381	1308	1312	mRNA	T114,T123	C0035696
27794381	1316	1318	GS	T047	C1392480
27794381	1324	1338	down-regulated	T044	C0013081
27794381	1344	1351	protein	T116,T123	C0033684
27794381	1356	1360	mRNA	T114,T123	C0035696
27794381	1364	1366	Gi	T116,T126	C0086706
27794381	1371	1374	Cap	T116,T123	C0073423
27794381	1380	1392	up-regulated	T044	C0041904
27794381	1394	1400	Emodin	T109,T121,T123	C0013982
27794381	1401	1414	significantly	T078	C0750502
27794381	1415	1424	decreased	T081	C0205216
27794381	1429	1438	formative	T169	C1522492
27794381	1439	1443	rate	T081	C1521828
27794381	1447	1456	gallstone	T047	C1392480
27794381	1471	1481	pathogenic	T033	C3816499
27794381	1482	1488	change	T169	C0392747
27794381	1492	1508	epithelial cells	T025	C0014597
27794381	1513	1525	muscle cells	T025	C0596981
27794381	1537	1540	CCK	T116,T121,T125	C0008328
27794381	1541	1547	levels	T080	C0441889
27794381	1551	1557	plasma	T031	C0032105
27794381	1562	1571	[Ca(2+)]i	T121,T196	C0596235
27794381	1575	1584	cholecyst	T023	C0016976
27794381	1585	1590	cells	T025	C0596981
27794381	1605	1612	protein	T116,T123	C0033684
27794381	1617	1621	mRNA	T114,T123	C0035696
27794381	1625	1627	Gs	T116,T126	C0086903
27794381	1631	1640	cholecyst	T023	C0016976
27794381	1641	1646	cells	T025	C0596981
27794381	1648	1655	reduced	T080	C0392756
27794381	1660	1667	protein	T116,T123	C0033684
27794381	1672	1676	mRNA	T114,T123	C0035696
27794381	1680	1682	Gi	T116,T126	C0086706
27794381	1687	1690	Cap	T116,T123	C0073423
27794381	1694	1703	cholecyst	T023	C0016976
27794381	1704	1709	cells	T025	C0596981
27794381	1713	1723	guinea pig	T015	C0085979
27794381	1729	1749	cholesterol calculus	T031	C0333018
27794381	1755	1766	dysfunction	T077	C3887504
27794381	1770	1793	gallbladder contraction	T042	C0232772
27794381	1812	1821	disorders	T047	C0012634
27794381	1825	1860	mobility signal transduction system	T043	C0037083
27794381	1864	1873	cholecyst	T023	C0016976
27794381	1874	1893	smooth muscle cells	T025	C0596981
27794381	1895	1904	including	T169	C0332257
27794381	1920	1926	plasma	T031	C0032105
27794381	1927	1930	CCK	T116,T121,T125	C0008328
27794381	1935	1944	[Ca(2+)]i	T121,T196	C0596235
27794381	1948	1957	cholecyst	T023	C0016976
27794381	1958	1963	cells	T025	C0596981
27794381	1965	1981	abnormal protein	T116,T123	C0311448
27794381	1986	1990	mRNA	T114,T123	C0035696
27794381	1994	1996	Gs	T116,T126	C0086903
27794381	1998	2000	Gi	T116,T126	C0086706
27794381	2005	2008	Cap	T116,T123	C0073423
27794381	2010	2016	Emodin	T109,T121,T123	C0013982
27794381	2021	2028	enhance	T052	C2349975
27794381	2033	2063	contractibility of gallbladder	T042	C0232772
27794381	2068	2077	alleviate	T081	C0547047
27794381	2078	2089	cholestasis	T047	C0008370
27794381	2093	2103	regulating	T038	C1327622
27794381	2104	2110	plasma	T031	C0032105
27794381	2111	2114	CCK	T116,T121,T125	C0008328
27794381	2115	2121	levels	T080	C0441889
27794381	2123	2132	[Ca(2+)]i	T121,T196	C0596235
27794381	2136	2145	cholecyst	T023	C0016976
27794381	2146	2151	cells	T025	C0596981
27794381	2160	2167	protein	T116,T123	C0033684
27794381	2172	2176	mRNA	T114,T123	C0035696
27794381	2180	2182	Gs	T116,T126	C0086903
27794381	2184	2186	Gi	T116,T126	C0086706
27794381	2191	2194	Cap	T116,T123	C0073423